LAB vs O · rev $174.4M vs P/E 50, rev $5.27B
Standard Biotools Inc (LAB) versus Realty Income Corporation (O) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Realty Income Corporation (O) is a reit - retail company listed on NYSE.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported O revenue for 2024-12-31 was $5.27B. Net income was $867.3M. Revenue was up 29.2% from 2023-12-31 to 2024-12-31. O currently screens at market cap $56.48B and trailing P/E 49.6.
LAB currently screens at market cap $317.1M. O currently screens at market cap $56.48B and trailing P/E 49.6.
Not investment advice. Open the LAB and O stock pages for the full models.
Not investment advice.